The Society for Immunotherapy of Cancer's (SITC) 33rd Annual Meeting provides a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy.
The Annual Meeting consists of cutting-edge research presentations by experts in the field, both oral and poster abstract presentations, and ample opportunity for structured and informal discussions, including important networking opportunities. In addition, the meeting includes updates on major national and international initiatives coming from academia, government and industry, as well as important society projects.
Following SITC’s tradition of collaborating to advance the field, the 33rd Annual Meeting will feature sessions collaboratively-developed with reputable organizations whose missions complement and align with that of SITC’s. The meeting will conclude with the Hot Topic Symposium, an in-depth look at an emerging topic in the field.
Charles River is proud to present the following posters at this year's conference:
- A translational platform using primary human immune cells in vitro, syngeneic and humanized models in vivo to support and advance immune-oncology drug discovery | Patrick Fadden, PhD, Research Director, Charles River
- Measurement of adenosine and other immunomodulators in the tumor microenvironment by in vivo microdialysis | Arash Rassoulpour, PhD, Senior Director, Charles River
- Modulation of adenosine levels in the tumor microenvironment following treatment with anti-PD1 antibodies and oxaliplatin: an in vivo microdialysis study | Arash Rassoulpour, PhD, Senior Director, Charles River
- Defeating checkpoint resistance: Highly specific inhibition of latent TGFβ1 activation renders resistant solid tumors vulnerable to PD-1 blockade | In collaboration with Scholar Rock
For additional information on our conference participation or to schedule a meeting with our attending scientists, please email [email protected].